Skip to main content

PACEs in Medical Schools

Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening (JAMA)

 

By Giridhar Mohan, MPH; Sajal Chattopadhyay PhD.,  JAMA Oncol. Published online June 18, 2020. doi:10.1001/jamaoncol.2020.1460

Key Points

Question  What are the costs of interventions leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening, and are they cost-effective?

Findings  In this systematic review of 30 unique economic evaluations, the median intervention cost per participant was $123.87, the median incremental cost per additional person screened was $250.37, and the median incremental cost per quality-adjusted life-year gained was $3120.00, which was considerably lower than an established conservative threshold for cost-effectiveness.

Meaning  This study found that interventions focused on social determinants of health to improve breast, cervical, and colorectal cancer screening appear to be cost-effective for underserved, vulnerable populations in the United States.

[Please click here to read more.]

Add Comment

Comments (0)

Copyright ÂĐ 2023, PACEsConnection. All rights reserved.
×
×
×
×
Link copied to your clipboard.
×